1. Home
  2. DRCT vs ALZN Comparison

DRCT vs ALZN Comparison

Compare DRCT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRCT
  • ALZN
  • Stock Information
  • Founded
  • DRCT 2018
  • ALZN 2016
  • Country
  • DRCT United States
  • ALZN United States
  • Employees
  • DRCT N/A
  • ALZN N/A
  • Industry
  • DRCT Computer Software: Programming Data Processing
  • ALZN Medicinal Chemicals and Botanical Products
  • Sector
  • DRCT Technology
  • ALZN Health Care
  • Exchange
  • DRCT Nasdaq
  • ALZN Nasdaq
  • Market Cap
  • DRCT 8.9M
  • ALZN 9.0M
  • IPO Year
  • DRCT 2022
  • ALZN 2021
  • Fundamental
  • Price
  • DRCT $0.20
  • ALZN $2.28
  • Analyst Decision
  • DRCT Strong Buy
  • ALZN Strong Buy
  • Analyst Count
  • DRCT 1
  • ALZN 1
  • Target Price
  • DRCT $6.00
  • ALZN $42.00
  • AVG Volume (30 Days)
  • DRCT 5.9M
  • ALZN 99.9K
  • Earning Date
  • DRCT 11-06-2025
  • ALZN 12-11-2025
  • Dividend Yield
  • DRCT N/A
  • ALZN N/A
  • EPS Growth
  • DRCT N/A
  • ALZN N/A
  • EPS
  • DRCT N/A
  • ALZN N/A
  • Revenue
  • DRCT $35,369,000.00
  • ALZN N/A
  • Revenue This Year
  • DRCT $16.81
  • ALZN N/A
  • Revenue Next Year
  • DRCT $35.28
  • ALZN N/A
  • P/E Ratio
  • DRCT N/A
  • ALZN N/A
  • Revenue Growth
  • DRCT N/A
  • ALZN N/A
  • 52 Week Low
  • DRCT $0.19
  • ALZN $2.06
  • 52 Week High
  • DRCT $6.59
  • ALZN $14.31
  • Technical
  • Relative Strength Index (RSI)
  • DRCT 32.51
  • ALZN 41.05
  • Support Level
  • DRCT $0.19
  • ALZN $2.31
  • Resistance Level
  • DRCT $0.42
  • ALZN $2.61
  • Average True Range (ATR)
  • DRCT 0.05
  • ALZN 0.15
  • MACD
  • DRCT -0.01
  • ALZN -0.02
  • Stochastic Oscillator
  • DRCT 6.12
  • ALZN 4.26

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: